At monthly cost of $7,000, costly new medicine aimed at estimated 20,000 Americans who have myelofibrosis
Read the rest here:
FDA okays Jakafi, first drug for rare marrow disease
If you enjoyed this post, make sure you subscribe to my RSS feed!
At monthly cost of $7,000, costly new medicine aimed at estimated 20,000 Americans who have myelofibrosis
Read the rest here:
FDA okays Jakafi, first drug for rare marrow disease
Tagged with: aimed-at-estimated costly-new medicine-aimed monthly-cost news